Fluxome Establishes U.S. Headquarters in Maryland

August 30, 2012

“The BioPark and Baltimore immediately felt like a ‘home’ for Fluxome,” says Angela Tsetsis, Fluxome’s president and CEO.

Fluxome Inc., supplier of Fluxome resveratrol and other ingredients, has established its U.S. headquarters and commercial operations at biomedical research park the University of Maryland BioPark, located at 801 W. Baltimore St., Baltimore, MD, 21201.

“The BioPark and Baltimore immediately felt like a ‘home’ for Fluxome with the people, dynamics, and resources available in a convenient central location that support the development of establishing a presence in the United States,” says Angela Tsetsis, Fluxome’s president and CEO.